Is AP4M1 p.Pro166Ser (c.496C>T) pathogenic?

AP4M1 p.Pro166Ser (c.496C>T) is classified Uncertain significance in AP4M1 (ClinVar, Multiple submitters, 2 submitters; last evaluated 2025-07-24). AlphaMissense: ambiguous (0.5576); Ultra-rare (popmax 0.0116%, nfe); Associated with hereditary spastic paraplegia 50.

What condition is associated with AP4M1 p.Pro166Ser (c.496C>T)?

AP4M1 p.Pro166Ser (c.496C>T) is associated with hereditary spastic paraplegia 50 (ClinVar).

How common is AP4M1 p.Pro166Ser (c.496C>T) in the general population?

AP4M1 p.Pro166Ser (c.496C>T) is ultra-rare (popmax 0.0116%, nfe) (gnomAD).

What do computational predictors say about AP4M1 p.Pro166Ser (c.496C>T)?

AlphaMissense predicts ambiguous (score 0.5576) — an in-silico prediction, not a clinical call.

AP4M1 p.Pro166Ser

Q: How is Severe intellectual disability and progressive spastic paraplegia inherited?

Typically Autosomal recessive (Orphanet). A genetic counselor can assess individual risk for a family.

c.496C>T · rs201290190 · VCV388602

Uncertain significance Multiple submitters

Classification

Uncertain significance

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 2 submitters

AlphaMissense

ambiguous

0.5576 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.0116%, nfe)

Conditions

hereditary spastic paraplegia 50

Computational evidence

Protein change
AlphaMissense	0.5576	ambiguous
REVEL	0.572	indeterminate
SaProt	LLR -6.76	tolerated
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 7.6	GERP 1.9, phastCons 1
Regional constraint	o/e 1.07	unconstrained · MANE · 5,164 bp · p 0.093 · regional, not allelic
Overall
CADD	26.3	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0116% European (non-Finnish) · 137/1,180,014 alleles

Filtering AF 0.01% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00939%

Overall 0.0088% 142/1,613,508 alleles · ultra-rare exomes 137/1,461,398 · genomes 5/152,110 · joint denominator

Ancestry group	Frequency	1 in
European (non-Finnish)grpmax	0.0116%	8,613
Remaining individualsnot grpmax-eligible	0.00641%	15,609
African / African-American	0.00134%	74,890

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: AP4M1
Protein: p.Pro166Ser
Coding: c.496C>T
MANE Select: NM_004722
dbSNP: rs201290190
Type: single nucleotide variant
Location: chr7:100103645 (GRCh38)
Gene constraint: LOEUF 1.106 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 86.16 · 6 PDB

Full AP4M1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary spastic paraplegia 50 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Severe intellectual disability and progressive spastic paraplegia (Orphanet):

Inheritance: Autosomal recessive
Onset: Infancy, Neonatal

Similar variants

AP4M1 c.1137+1G>T Pathogenic/Likely pathogenic ★★ same condition
AP4M1 c.930-1G>C Likely pathogenic ★★ same condition
AP4M1 p.Arg268Ter Pathogenic ★★ same condition
AP4M1 p.Arg306Ter Pathogenic ★★ same condition
AP4M1 p.Arg318Ter Pathogenic ★★ same condition
AP4M1 p.Arg338Ter Pathogenic/Likely pathogenic ★★ same condition
AP4M1 p.Cys319Arg Pathogenic/Likely pathogenic ★★ same condition
AP4M1 p.Gln183Ter Pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ap4m1-p-pro166ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown